Drug Profile
Parietaria pollen allergy immunotherapy - Lofarma
Alternative Names: Lais Parietaria; LAIS Parietaria allergy vaccine - Lofarma; SLIT Parietaria - LofarmaLatest Information Update: 20 Apr 2016
Price :
$50
*
At a glance
- Originator Lofarma S.p.A
- Class Allergens; Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rhinoconjunctivitis
Most Recent Events
- 26 Oct 2009 Phase-III clinical trials in Rhinoconjunctivitis in Italy (Sublingual)